Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05588453
Title Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Kari Kendra
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.